KHAPRE
DEAD

Serial Number

79241068

Owner

BIOACTIVE SOLUTIONS PTY LTD

Filing Date

Mar 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

KHAPRE Trademark

Serial Number: 79241068

KHAPRE is a trademark filed by BIOACTIVE SOLUTIONS PTY LTD on March 2, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BIOACTIVE SOLUTIONS PTY LTD

56 Alderbury St

Entity Type: 98

Trademark Details

Filing Date

March 2, 2018

Registration Date

Not Registered

Goods & Services

Dental health gum (medicated); healthcare products (medicinal); natural healthcare preparations (medicaments); pharmaceutical preparations for health care; animal care products for veterinary use; antibiotic food supplements for animals; antiparasitic collars for animals; dietary supplements for animals; massage creams for animals for veterinary purposes; medicated food additives for animals; medicinal food supplements for animals; nutritional animal feed supplements; acne cleansers (pharmaceutical preparations); acne creams (pharmaceutical preparations); anti-bacterial pharmaceutical preparations; anti-cancer pharmaceutical preparations; anti-sunburn products for pharmaceutical use; barks for pharmaceutical purposes; biochemicals for pharmaceutical use; biological preparations for pharmaceutical purposes; capsules for pharmaceutical purposes; capsules for veterinary pharmaceutical preparations; decoctions for pharmaceutical purposes; digestives for pharmaceutical purposes; extracts of plants in capsule form (for pharmaceutical use); homeopathic pharmaceuticals; lozenges for pharmaceutical purposes; moist wipes impregnated with a pharmaceutical lotion; moistened paper tissues impregnated with a pharmaceutical lotion; moisturisers (pharmaceuticals); moisturising preparations (pharmaceutical); natural pharmaceutical products; oils adapted for pharmaceutical purposes; oils for pharmaceutical purposes; patches incorporating a pharmaceutical preparation for application to the skin; pharmaceutical compound eye-drops; pharmaceutical creams; pharmaceutical drugs; pharmaceutical lipsalves; pharmaceutical preparations; pharmaceutical preparations being antiulceratives; pharmaceutical preparations contained in transdermal patches; pharmaceutical preparations containing a vasodilator; pharmaceutical preparations containing essential oils; pharmaceutical preparations containing vitamins; pharmaceutical preparations for animals; pharmaceutical preparations for application to the skin; pharmaceutical preparations for enteral administration; pharmaceutical preparations for human use; pharmaceutical preparations for skin care; pharmaceutical preparations for the relief of insect stings; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for the treatment of blackheads; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of digestive maladies; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical preparations for the treatment of pimples; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for topical use; pharmaceutical preparations for use as laxative; pharmaceutical preparations for use in dentistry; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for use in the treatment of arthrosis; pharmaceutical preparations for use in the treatment of rheumatism; pharmaceutical preparations for use in the treatment of seborrheic dermatitis; pharmaceutical preparations for use with an automated bacterial protection; pharmaceutical preparations for veterinary use; pharmaceutical preparations in the form of tablets; pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical products for the treatment of gastrointestinal disorders; pharmaceutical products for the treatment of osteoporosis; pharmaceutical products in the nature of anthelmintic preparations; pharmaceutical substances; pharmaceutical tablets; pharmaceutical tonic preparations; plant extracts for pharmaceutical use; preparations for application to the body (pharmaceuticals); preparations for application to the scalp (pharmaceuticals); preparations for application to the skin (pharmaceuticals); preparations for body care (pharmaceuticals); preparations for sun protection (pharmaceutical); preparations of plants for pharmaceutical use; skin patches for the transdermal delivery of pharmaceuticals; skincare preparations (pharmaceutical); sprays for use on the body (pharmaceuticals); swabs impregnated with pharmaceutical preparations; syrups for pharmaceutical purposes; tissues impregnated with pharmaceutical lotions; topical pharmaceutical compositions; transdermal patches for administering pharmaceuticals; wipes (tissues) impregnated with pharmaceutical lotions

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 5, 2020 FINT
FINAL DISPOSITION NOTICE SENT TO IB
May 20, 2020 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 20, 2020 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 13, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 26, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 26, 2020 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 20, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 20, 2019 ABN2
REFUSAL PROCESSED BY IB
Oct 26, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 5, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 5, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 28, 2018 MAFR
ASSIGNED TO EXAMINER
Sep 24, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 20, 2018 REPR